Skip to main content
Top
Published in: Internal and Emergency Medicine 3/2016

01-04-2016 | IM - EDITORIAL

Chronic disease in the ethnic minority and migrant groups: time for a paradigm shift in Europe

Authors: Pietro Amedeo Modesti, Francesco Perticone, Gianfranco Parati, Enrico Agabiti Rosei, Domenico Prisco

Published in: Internal and Emergency Medicine | Issue 3/2016

Login to get access

Excerpt

In this issue of the Journal, a series of articles belonging to the Topical Collection “Focus on healthcare and non-communicable disease in migrants” addresses the health of a stably growing proportion of subjects in the European (EU) countries. In 1990, just over 2 % of the population living in Italy was born elsewhere, [1] and a physician had few opportunities to meet a person belonging to an ethnic minority in the hospital ward or outpatient clinic. Over the past few decades, this scenario has changed dramatically. The fall of the iron curtain in 1989 opened migration flows from central and eastern EU countries mainly towards Germany, Turkey, and Finland. Meanwhile, growing flows from the countries of the south created a new “migration frontier” along the northern shores of the Mediterranean. Italy, Greece, Spain, and Portugal, traditionally countries of emigration, became countries of net immigration [1]. As a result in 2015, an estimated 76 million international long-term migrants, defined by the UN as a “person who moves to a country other than that of his or her usual residence for a period of at least a year” [2], lived in the WHO European region, 8.5 million more than in 2005 [1, 3]. The possibility of meeting these new patients in the hospital ward or outpatient clinic is now high. Notwithstanding these relevant changes, scientific and cultural training of health workers on the health needs of minority groups is still limited and probably skewed [4]. The infectious disease specialists have traditionally been considered experts in the field of migration medicine, because it was thought that the large majority of the diseases affecting migrants had to be infectious or tropical (“exotic”) in nature. However, when we face people born in low-income countries who permanently live and work in Europe, we have to consider that this paradigm is probably shifted [5]. …
Literature
3.
go back to reference International Organization for Migration. World Migration Report (2015) Migrants and cities: new partnerships to manage mobility. International Organization for Migration, Geneva, p 2015 International Organization for Migration. World Migration Report (2015) Migrants and cities: new partnerships to manage mobility. International Organization for Migration, Geneva, p 2015
11.
go back to reference Lambie M, Richards N, Smith S (2008) Ethnicity, age and incidence rates for renal replacement therapy (RRT) in Birmingham, UK: 1990–2004. Nephrol Dial Transpl 23(12):3983–3987. doi:10.1093/ndt/gfn366 CrossRef Lambie M, Richards N, Smith S (2008) Ethnicity, age and incidence rates for renal replacement therapy (RRT) in Birmingham, UK: 1990–2004. Nephrol Dial Transpl 23(12):3983–3987. doi:10.​1093/​ndt/​gfn366 CrossRef
12.
go back to reference McKeigue PM, Miller GJ, Marmot MG (1989) Coronary heart disease in South Asians overseas: a review. J Clin Epidemiol 42(7):597–609CrossRefPubMed McKeigue PM, Miller GJ, Marmot MG (1989) Coronary heart disease in South Asians overseas: a review. J Clin Epidemiol 42(7):597–609CrossRefPubMed
13.
go back to reference Forouhi NG, Sattar N, Tillin T, McKeigue PM, Chaturvedi N (2006) Do known risk factors explain the higher coronary heart disease mortality in South Asian compared with European men? Prospective follow-up of the Southall and Brent studies, UK. Diabetologia 49(11):2580–2588CrossRefPubMed Forouhi NG, Sattar N, Tillin T, McKeigue PM, Chaturvedi N (2006) Do known risk factors explain the higher coronary heart disease mortality in South Asian compared with European men? Prospective follow-up of the Southall and Brent studies, UK. Diabetologia 49(11):2580–2588CrossRefPubMed
15.
go back to reference Modesti PA, Agostoni P, Agyemang C, Basu S, Benetos A, Cappuccio FP, Ceriello A, Del Prato S, Kalyesubula R, O’Brien E, Kilama MO, Perlini S, Picano E, Reboldi G, Remuzzi G, Stuckler D, Twagirumukiza M, Van Bortel LM, Watfa G, Zhao D, Parati G (2014) Cardiovascular risk assessment in low-resource settings: a consensus document of the European Society of Hypertension Working Group on hypertension and cardiovascular risk in low resource settings. J Hypertens 32(5):951–960. doi:10.1097/Hjh.0000000000000125 CrossRefPubMedPubMedCentral Modesti PA, Agostoni P, Agyemang C, Basu S, Benetos A, Cappuccio FP, Ceriello A, Del Prato S, Kalyesubula R, O’Brien E, Kilama MO, Perlini S, Picano E, Reboldi G, Remuzzi G, Stuckler D, Twagirumukiza M, Van Bortel LM, Watfa G, Zhao D, Parati G (2014) Cardiovascular risk assessment in low-resource settings: a consensus document of the European Society of Hypertension Working Group on hypertension and cardiovascular risk in low resource settings. J Hypertens 32(5):951–960. doi:10.​1097/​Hjh.​0000000000000125​ CrossRefPubMedPubMedCentral
17.
go back to reference Bijker R and Agyemang C (2015) The influence of early-life conditions on cardiovascular disease later in life among ethnic minority populations: a systematic review. Intern Emerg Med. doi: 10.1007/s11739-015-1272-y Bijker R and Agyemang C (2015) The influence of early-life conditions on cardiovascular disease later in life among ethnic minority populations: a systematic review. Intern Emerg Med. doi: 10.​1007/​s11739-015-1272-y
19.
go back to reference Meeks KA, Freitas-Da-Silva D, Adeyemo A, Beune EJ, Modesti PA, Stronks K, Zafarmand MH, Agyemang C (2015) Disparities in type 2 diabetes prevalence among ethnic minority groups resident in Europe: a systematic review and meta-analysis. Intern Emerg Med. doi: 10.1007/s11739-015-1302-9 Meeks KA, Freitas-Da-Silva D, Adeyemo A, Beune EJ, Modesti PA, Stronks K, Zafarmand MH, Agyemang C (2015) Disparities in type 2 diabetes prevalence among ethnic minority groups resident in Europe: a systematic review and meta-analysis. Intern Emerg Med. doi: 10.​1007/​s11739-015-1302-9
20.
21.
22.
go back to reference Brewster LM, van Montfrans GA, Oehlers GP, Seedat YK (2016) Systematic review: antihypertensive drug therapy in patients of African and South Asian ethnicity. Intern Emerg Med. doi:10.1007/s11739-016-1422-x Brewster LM, van Montfrans GA, Oehlers GP, Seedat YK (2016) Systematic review: antihypertensive drug therapy in patients of African and South Asian ethnicity. Intern Emerg Med. doi:10.​1007/​s11739-016-1422-x
Metadata
Title
Chronic disease in the ethnic minority and migrant groups: time for a paradigm shift in Europe
Authors
Pietro Amedeo Modesti
Francesco Perticone
Gianfranco Parati
Enrico Agabiti Rosei
Domenico Prisco
Publication date
01-04-2016
Publisher
Springer Milan
Published in
Internal and Emergency Medicine / Issue 3/2016
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-016-1444-4

Other articles of this Issue 3/2016

Internal and Emergency Medicine 3/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.